The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[4-(3-(N,N-dimethyl)amino-phenoxy)-phenyl]-1H-benzoimidazole-5-carboxylic acid amide ID: ALA3982788
PubChem CID: 10156124
Max Phase: Preclinical
Molecular Formula: C22H20N4O2
Molecular Weight: 372.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)c1cccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1
Standard InChI: InChI=1S/C22H20N4O2/c1-26(2)16-4-3-5-18(13-16)28-17-9-6-14(7-10-17)22-24-19-11-8-15(21(23)27)12-20(19)25-22/h3-13H,1-2H3,(H2,23,27)(H,24,25)
Standard InChI Key: COGXEORJSOQOLI-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
8.1736 -4.2285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6891 -3.5633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9119 -3.8158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9119 -4.6371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6891 -4.8938 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2001 -3.4072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4882 -3.8158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4882 -4.6371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2001 -5.0498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7764 -3.4072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7764 -2.5859 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0646 -3.8158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9949 -4.2285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4076 -3.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2289 -3.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6375 -4.2285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2289 -4.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4076 -4.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4588 -4.2285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8716 -4.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6929 -4.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1015 -5.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6929 -6.3599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8716 -6.3599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4588 -5.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9228 -5.6481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3355 -4.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3355 -6.3599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
3 6 2 0
10 11 2 0
10 12 1 0
7 10 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
20 25 2 0
19 20 1 0
26 27 1 0
26 28 1 0
22 26 1 0
16 19 1 0
1 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.43Molecular Weight (Monoisotopic): 372.1586AlogP: 4.19#Rotatable Bonds: 5Polar Surface Area: 84.24Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.08CX Basic pKa: 4.48CX LogP: 3.74CX LogD: 3.74Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.55Np Likeness Score: -1.37
References 1. (2007) 2-phenyl benzimidazoles and imidazo-4,5|-pyridines as CDS1/CHK2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer,